Generated by GPT-5-mini| Bill Maris | |
|---|---|
| Name | Bill Maris |
| Birth date | 1975 |
| Birth place | United States |
| Occupation | Venture capitalist, entrepreneur, investor |
| Known for | Founding and leading Google Ventures |
| Alma mater | Brown University, University of Pennsylvania |
Bill Maris is an American venture capitalist and entrepreneur best known for founding and leading Google Ventures. He helped shape early-stage investment strategies in technology and life sciences, directing capital toward startups in biotechnology, artificial intelligence, and consumer internet. His work bridges Silicon Valley finance, biomedical research, and philanthropic science initiatives.
Born in the United States in 1975, Maris grew up during the rise of personal computing and the internet era. He attended Brown University where he studied cognitive science and computer science, and later pursued further education at the University of Pennsylvania. During his student years he engaged with emerging startups and research labs associated with institutions such as MIT Media Lab, Stanford University programs, and regional incubators.
Maris began his career in technology and investment, joining early-stage firms that intersected with companies like Google and PayPal. He served in roles that connected venture funding and product strategy, collaborating with entrepreneurs associated with YouTube, Twitter, Facebook, and founders from the Silicon Valley ecosystem. His network extended to leaders at Sequoia Capital, Andreessen Horowitz, Accel Partners, and Benchmark during the 2000s tech expansion. Maris developed investment theses informed by trends in biotech startups and computational approaches seen at labs like Broad Institute and companies such as Illumina.
In 2009 Maris founded and became CEO of Google Ventures, the corporate venture capital arm initially funded by Alphabet Inc. and associated with Google X. Under his leadership, the firm invested in startups spanning healthcare, robotics, software, and consumer services, including portfolio companies such as Uber Technologies, Nest Labs, Flatiron Health, Genomics startups, and Stripe. He structured GV to provide design, recruiting, and engineering support, coordinating with teams at YouTube, Android, Waymo, and Calico. Maris emphasized long-term bets in life sciences, forming partnerships with research institutions like the Salk Institute, Dana-Farber Cancer Institute, and Johns Hopkins University. During his tenure GV grew into a major investor, competing with firms like Kleiner Perkins and General Catalyst and collaborating with corporate venture groups such as Intel Capital and Salesforce Ventures.
After leaving Google Ventures, Maris founded and led new investment vehicles focused on longevity, genomics, and deep tech, working with co-investors from Lux Capital, GV, and Sequoia Capital. He launched funds and companies that partnered with academic centers including the Scripps Research Institute, Harvard Medical School, and the University of California, San Francisco. Maris backed startups developing gene therapies, CRISPR applications associated with labs like Broad Institute and CRISPR Therapeutics, and computational biology firms influenced by platforms such as TensorFlow and PyTorch. His investments connected to diagnostics companies akin to 23andMe and sequencing companies similar to Pacific Biosciences. He also engaged with aerospace and AI ventures linked to SpaceX and research groups at OpenAI.
Maris directed philanthropic efforts toward biomedical research, longevity science, and public health partnerships, collaborating with institutions like National Institutes of Health, Howard Hughes Medical Institute, and private research consortia. He supported initiatives to accelerate translational research between universities such as MIT, Stanford University, and clinical centers including Massachusetts General Hospital. His advocacy included funding early-stage projects in synthetic biology, regenerative medicine, and precision oncology, aligned with entities similar to Cancer Research Institute and consortia of biopharma companies. Maris also sponsored education and mentorship programs connected to incubators like Y Combinator and university entrepreneurship centers.
Maris resides in the United States and remains active in advising startups, research projects, and investment firms. His legacy includes establishing a model for corporate venture capital that integrates operational support with long-term scientific investment, influencing firms such as Temasek Holdings and SoftBank Vision Fund in their healthcare allocations. He is recognized by peers at organizations like World Economic Forum and has been featured in publications alongside profiles of leaders from Apple Inc., Microsoft, Amazon (company), and Tesla, Inc. for shaping the intersection of technology and life sciences.
Category:American venture capitalists